Overview

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Status:
Unknown status

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of apatinib as maintenance therapy after first-line chemotherapy in Postoperative Recurrence / Metastasis Progressive Gastric Cancer.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Hebei Medical University

Collaborator:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

Apatinib